Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This phase II/III trial studies how well anamorelin hydrochloride works in reducing anorexia
in patients with non-small cell lung cancer that has spread to other places in the body.
Anamorelin hydrochloride may help to improve patients' appetite in order to stop weight loss.